Source: Annual Congress 2010 - Sepsis and multiorgan failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Chen, H. Gao, X. Wang, B. Geng, W. Yao, C. Tang (Beijing, China). Endogenous hydrogen sulfide in patients with suspected sepsis and its diagnostic accuracy. Eur Respir J 2010; 36: Suppl. 54, 3635

Member's Comments

No comment yet.

Related content which might interest you: Effect of theophylline on endogenous hydrogen sulfide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Endogenous hydrogen sulfide (H2S) in serum and sputum as novel biomarker of asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014 A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 Role of endogenous hydrogen sulfide in the patients with lower respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007 Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001 Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005 Hydrogen peroxide assessment in a paediatric population Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008 Diagnostic value of nonproteic sulphur in pulmonary infections Source: Eur Respir J 2006; 28: Suppl. 50, 4s Year: 2006 Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 Variation of exhaled hydrogen peroxide in stable COPD patients and matched healthy persons over time Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Increased concentration of hydrogen peroxide (H2O2) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 NO and CO: overview of their diagnostic potential in the critically ill patient Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005 Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Clinical aspects of acute nickel carbonyl poisoning in a cluster of patients working at a chemical processing plant Source: Eur Respir J 2004; 24: Suppl. 48, 365s Year: 2004 Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases Source: Annual Congress 2008 - COPD Year: 2008 The value of exhaled breath condensate ‘pH‘ to evaluate the severity of disease and the response to treatment in patients with community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001